Dipentum is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Olsalazine Sodium.
| Product ID | 68151-0312_75c040b8-d3c3-4df8-adb9-af948f9bc0dd |
| NDC | 68151-0312 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dipentum |
| Generic Name | Olsalazine Sodium |
| Dosage Form | Capsule, Gelatin Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-05-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019715 |
| Labeler Name | Carilion Materials Management |
| Substance Name | OLSALAZINE SODIUM |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2017-12-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019715 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-12-26 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| OLSALAZINE SODIUM | 250 mg/1 |
| SPL SET ID: | 9dd522a3-587e-44ab-9de3-a0fd079f2ffb |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0037-6860 | Dipentum | olsalazine sodium |
| 68151-0312 | Dipentum | olsalazine sodium |
| 68151-3120 | Dipentum | olsalazine sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DIPENTUM 76481658 not registered Dead/Abandoned |
Celltech Pharmaceuticals, Inc. 2003-01-13 |
![]() DIPENTUM 76481657 not registered Dead/Abandoned |
Celltech Pharmaceuticals, Inc. 2003-01-13 |
![]() DIPENTUM 73506342 1337522 Live/Registered |
Pharmacia, Inc. 1984-10-30 |